Fast Five Quiz: Relapsed/Refractory Marginal Zone Lymphoma

Christina Poh, MD

Disclosures

November 03, 2021

Marginal zone lymphoma (MZL) describes a heterogeneous group of indolent lymphoproliferative disorders derived from post–germinal center marginal zone B cells. It is further categorized into subtypes on the basis of predominant area of disease involvement. Extranodal MZL of mucosa-associated lymphoid tissue (known as MALT lymphoma) primarily affects extranodal tissues, whereas nodal and splenic MZL primarily affects the lymph nodes and spleen, respectively. Treatment approach is dependent on MZL subtype.

How should relapsed/refractory MZL be treated? Test your knowledge with this quick quiz.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....